i vi da v sc khe xng khp ti tui 30, liu lng khong 3000mg/ngy c khuyn khch
They will guide you on dose adjustments, monitor any side effects, and help manage potential risks associated with treatment
Molecules 27 (1), 146
In PD, mutations in GBA, ATP13A2, and PARK9 impair lysosomal function, leading to -synuclein accumulation and cellular toxicity (Behl et al., 2022
(1993) Insulin-like Growth Factor (IGF) Binding Proteins Inhibit the Biological Activities of IGF-1 and IGF-2 but Not des-(13)-IGF-1 PMC1138350 Clemmons D et al
The Phase 2 trial reference point The Phase 2 retatrutide trial (Jastreboff et al., New England Journal of Medicine 2023) enrolled 338 adults across placebo and retatrutide arms at 1, 4, 8, and 12 mg weekly